A randomised feasibility study of Eicosapentaenoic acid (EPA) and Cox-2 inhibitor versus EPA, Cox-2 inhibitor, Progressive Resistance Training followed by essential amino acids high in leucine in NSCLC cachectic patients: Results from the ACCeRT study

A randomised feasibility study of Eicosapentaenoic acid (EPA) and Cox-2 inhibitor versus EPA, Cox-2 inhibitor, Progressive Resistance Training followed by essential amino acids high in leucine in NSCLC cachectic patients: Results from the ACCeRT study

Rogers, Elaine ; Sasidharan, R ; Sequeira, G ; Wood, MR ; Bird, SP ; Keogh, JWL ; Arroll, Bruce ; Stewart, J ; MacLeod, RD
Identifier: http://hdl.handle.net/2292/42911
Issue Date: 2015-12
Reference: 8th International Conference on Cachexia, Sarcopenia and Muscle Wasting, Paris, France, 04 Dec 2015 - 06 Dec 2015. Journal of Cachexia, Sarcopenia and Muscle. 6: 495-496. Dec 2015
Rights: Copyright: The authors
Rights (URI): https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm

Show full item record

Files in this item

Icon
Size: 1.593Mb
Format: PDF
Icon
DOI: 10.1002/jcsm.12087
Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Browse

Statistics